Search

Issue
Title
Authors
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A.S., Tertychnaya E.A.
SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA
Ruyatkina L.A., Lomova A.V., Ruyatkin D.S.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N.A., Prudnikova M.A., Chernikova N.A., Prudnikova M.A.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M.B., Antciferov M.B.
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M.B., Antsiferov M.B.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M.B., Morgunov L.Y., Antsiferov M.B., Morgunov L.Y.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.V.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L.V., Nedosugova L.
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N.A., Martirosyan N.S., Valeeva F.V.
Obesity: an invisible disease
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I., Lomonova T.V.
Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»
Antsiferov M.B., Galstyan G.R.
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A.M., Markova T.N.
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
Antsiferov M.B., Kvasnikov B.B.
Apelin: biological and pathophysiological effects
Dolgikh Y.A., Verbovoy A.F.
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y.L., Martynyuk M.V.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.A.
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.V.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.R.
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M.B., Koteshkova O.M.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.S.
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I.Y., Boeva V.V.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.V.
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T.V., Nikonova T.V.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antciferov M.B.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Trukhina L.V., Petunina N.A., Truhina L.V.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Petunina N.A.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M.B., Antsiferov M.
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M.B., Demidov N.A., Safronova T.I., Mishra O.A.
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P.B., Baranov V.L.
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
Shchukina E.V., Gromenkov V.D., Suprun Y.V., Mykhailichenko E.S., Beryozova E.V., Bagriy V.A., Golodnikov I.A.
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
Markova T.N.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.V.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A.V., Verbovoy A.F.
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.B.
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M.E., Derevyanchenko M.V.
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E.V., Antsiferov M.B., Biryukova Y.V., Antsiferov M.B.
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M.B., Koteshkova O.M., Kleymenova S.A., Antsiferov M.B., Koteshkova O.M., Kleimenko S.A.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y.V., Biryukova E.V.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V.V., Chazova I., Fomin V.
Insulin resistance and heart diseases: is there a relationship?
Drapkina O.M., Smirin V.I., Ivashkin V.T., Drapkina O.M., Smirin V.I., Ivaschkin V.T.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A.V., Volkova A.R., Chernaya M.E., Mozgunova V.S., Durdyeva M.B.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N.А., Baranova N.I., Fedin A.V.
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E.V., Solovyova I.V.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I.G., Kaukova A.N., Belyakova N.A., Vasyutkova O.A., Konovalova O.V., Lareva A.V.
Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients
Kovrigina E.V., Tyulganova V.L.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I.G., Vinnytskaya E.V., Sandler Y.G., Keiyan V.A., Rodionova S.V.
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M.S., Nazhmutdinova P.K., Ametov A.S.
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa
Antsiferov M.B.
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N.A., Trukhina L.V., Sinitsyna E.I., Antsiferov M.B.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A.F., Vorozhtsova E.I., Orlova T.N.
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Brashchenkova A.V., Petunina N.A., Brashcenkova A.V.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E.V., pl?midmagidsid Y.h.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M.B., Koteshkova O.M., Kleimenova S.A., Antsiferov M.B., Koteshkova O.M., Kleymenova S.A.
Common bean (Phaseolus vulgaris L.)/
Samylina I.A., Sorokina A.A., Pyatigorskaya N.V., Samylina I., Sorokina A., Pyatigorskaya N.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M.S., Koteshkova O.M., Antsiferov M.B.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.A.
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
Shevkunova N.A., Vorobyov M.V., Gushchin V.V.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L.A., Verbovoy A.F.
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A.M., Podachina S.V., Sviridova M.I.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V.I., Nichitenko M.S., Chesnikova A.I.
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N.A., Ametov A.S., Antsiferov M.B.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.S.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Dorofeeva L.G.
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M.B., Ametov A.S., Zilov A.V., Antsiferov M.B., Ametov A.S., Zilov A.V.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M.B., Antsiferov M.B.
101 - 177 of 177 Items << < 1 2 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies